JP2011516478A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516478A5 JP2011516478A5 JP2011502995A JP2011502995A JP2011516478A5 JP 2011516478 A5 JP2011516478 A5 JP 2011516478A5 JP 2011502995 A JP2011502995 A JP 2011502995A JP 2011502995 A JP2011502995 A JP 2011502995A JP 2011516478 A5 JP2011516478 A5 JP 2011516478A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- effective
- cytostatic
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4221008P | 2008-04-03 | 2008-04-03 | |
| US61/042,210 | 2008-04-03 | ||
| PCT/US2009/002134 WO2009145841A1 (en) | 2008-04-03 | 2009-04-03 | Compositions and methods for immunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011516478A JP2011516478A (ja) | 2011-05-26 |
| JP2011516478A5 true JP2011516478A5 (enExample) | 2012-05-24 |
Family
ID=41267359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011502995A Pending JP2011516478A (ja) | 2008-04-03 | 2009-04-03 | 免疫療法のための組成物および方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US20090281047A1 (enExample) |
| EP (1) | EP2271350A4 (enExample) |
| JP (1) | JP2011516478A (enExample) |
| CN (1) | CN102046180A (enExample) |
| AU (1) | AU2009251848A1 (enExample) |
| CA (1) | CA2757437A1 (enExample) |
| IL (1) | IL208445A0 (enExample) |
| MX (1) | MX339451B (enExample) |
| NZ (1) | NZ588668A (enExample) |
| RU (1) | RU2010144744A (enExample) |
| WO (1) | WO2009145841A1 (enExample) |
| ZA (1) | ZA201007830B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100160368A1 (en) | 2008-08-18 | 2010-06-24 | Gregory Jefferson J | Methods of Treating Dermatological Disorders and Inducing Interferon Biosynthesis With Shorter Durations of Imiquimod Therapy |
| EP2378876B1 (en) * | 2008-12-19 | 2018-11-14 | Medicis Pharmaceutical Corporation | Lower dosage strength imiquimod formulations and short dosing regimens for treating actinic keratosis |
| PL2453747T3 (pl) | 2009-07-13 | 2018-02-28 | Medicis Pharmaceutical Corporation | Preparaty imikwimodu o niższej mocy dawki i krótkie schematy dawkowania do leczenia brodawek narządów płciowych i okolic odbytu |
| CA2801891C (en) * | 2010-06-07 | 2020-10-27 | Abraxis Bioscience, Llc | Combination therapy methods for treating proliferative diseases |
| US20130171279A1 (en) * | 2012-01-04 | 2013-07-04 | Physicianrx, Llc | Composition for Reducing Side- and After-Effects of Cancer Treatment |
| CN103156951A (zh) * | 2013-04-11 | 2013-06-19 | 太仓市胜舟生物技术有限公司 | 一种治疗b细胞淋巴瘤的组合药物 |
| ES2886019T3 (es) * | 2013-12-20 | 2021-12-16 | Campillo Ramiro Moises Vergara | Combinación de piridoxina, ácido fólico e iones magnesio para el tratamiento del cáncer |
| CN117100734A (zh) | 2016-02-04 | 2023-11-24 | Sct二代有限责任公司 | 一种拓扑异构酶ii抑制剂及其用途和药物组合物 |
| CN113288862B (zh) * | 2016-08-03 | 2023-06-02 | 珠海贝海生物技术有限公司 | 含阿瑞吡坦的组合物及其制备方法和应用 |
| US20200360408A1 (en) * | 2017-08-07 | 2020-11-19 | Joe Emest BROWN | Compositions And Methods For Inducing Apoptosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections |
| IL307204A (en) * | 2021-03-25 | 2023-11-01 | Shmuel Robinov | Benzaldehyde extracted from rosales as foodstuff preservative, animal-feed additive, and for treatment of the covid-19 virus |
| JP7018531B1 (ja) | 2021-04-30 | 2022-02-10 | 潤 齋藤 | Ａｘｌ阻害剤 |
| US20250161234A1 (en) * | 2022-02-24 | 2025-05-22 | Shmuel ROBINOV | Methods of use of benzaldehyde compositions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4882314A (en) * | 1985-12-02 | 1989-11-21 | Rikagaku Kenkyusho | A composition and method of treating selected malignant conditions |
| US6407071B1 (en) * | 1998-06-04 | 2002-06-18 | Co-Enzyme Technology Ltd. | Method and composition for treating malignant cells |
| NO309305B1 (no) * | 1999-02-19 | 2001-01-15 | Norsk Hydro As | Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater |
-
2009
- 2009-04-03 MX MX2010010866A patent/MX339451B/es active IP Right Grant
- 2009-04-03 EP EP09755204A patent/EP2271350A4/en not_active Withdrawn
- 2009-04-03 RU RU2010144744/15A patent/RU2010144744A/ru not_active Application Discontinuation
- 2009-04-03 JP JP2011502995A patent/JP2011516478A/ja active Pending
- 2009-04-03 AU AU2009251848A patent/AU2009251848A1/en not_active Abandoned
- 2009-04-03 CA CA2757437A patent/CA2757437A1/en not_active Abandoned
- 2009-04-03 US US12/418,342 patent/US20090281047A1/en not_active Abandoned
- 2009-04-03 NZ NZ588668A patent/NZ588668A/xx not_active IP Right Cessation
- 2009-04-03 CN CN2009801205538A patent/CN102046180A/zh active Pending
- 2009-04-03 WO PCT/US2009/002134 patent/WO2009145841A1/en not_active Ceased
-
2010
- 2010-10-03 IL IL208445A patent/IL208445A0/en unknown
- 2010-11-02 ZA ZA2010/07830A patent/ZA201007830B/en unknown
-
2011
- 2011-08-19 US US13/213,819 patent/US20110311476A1/en not_active Abandoned
- 2011-08-19 US US13/214,022 patent/US20110311478A1/en not_active Abandoned
- 2011-08-19 US US13/213,933 patent/US20110311477A1/en not_active Abandoned
-
2012
- 2012-06-17 US US13/525,317 patent/US20120251490A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2010144744A (ru) | Композиции и способы иммунотерапии | |
| JP2020019812A5 (enExample) | ||
| US11730736B2 (en) | Anticancer agents | |
| JP2020514271A5 (enExample) | ||
| RU2018120318A (ru) | ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНОВЫЕ СОЕДИНЕНИЯ И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА | |
| KR101575706B1 (ko) | 암 치료용 선택적인 ｅｐ４ 수용체 길항제 | |
| ES2561495T3 (es) | Régimen de tratamiento que utiliza neratinib contra cáncer de mama | |
| RU2018142394A (ru) | Композиции и способы для лечения нейтропении | |
| JP2017525730A5 (enExample) | ||
| JP6198286B2 (ja) | 癌の処置のためのイソフラボノイド化合物および方法 | |
| JP2014510729A5 (enExample) | ||
| JP2012153722A5 (enExample) | ||
| JP2009536191A5 (enExample) | ||
| ES2877712T3 (es) | Terapias combinadas para su uso en el tratamiento del cáncer de mama | |
| JP2014511383A5 (enExample) | ||
| JP2012158602A5 (enExample) | ||
| HRP20220351T1 (hr) | 3,5-disupstituirani pirazoli korisni kao inhibitori kinaze 1 kontrolne točke (chk1), i njihove pripreme i primjene | |
| JP2018517686A5 (enExample) | ||
| JP2010525057A5 (enExample) | ||
| JP2013531068A (ja) | ４−ヨード−３−ニトロベンズアミドを抗腫瘍剤と組み合わせて用いる乳癌の治療方法 | |
| JP2017505785A5 (enExample) | ||
| AU2022409798A1 (en) | Use of combination therapy for treating cancer | |
| JP2012522841A5 (enExample) | ||
| JP2020514344A5 (enExample) | ||
| SI3174881T1 (en) | (1,2,4) triazolo (4,3-B) pyridazines for use in the treatment of proliferative diseases |